In addition, Kaplan-Meier survival curves combined with the log rank test showed that the prognosis of CRC patients with high expression of Gankyrin was poor, and that the five-year survival rate was significantly reduced (p < 0.001; Figure 4B). The gene discussed is PSMD10; the disease is colorectal carcinoma.